Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-α

被引:3
作者
Nagahira, K [1 ]
Fukuda, Y [1 ]
Nasu, T [1 ]
Kawashima, H [1 ]
Noguchi, C [1 ]
Kurihara, T [1 ]
Oikawa, S [1 ]
Nakanishi, T [1 ]
机构
[1] Suntory Inst Biomed Res, Shimamoto, Osaka 6188503, Japan
关键词
chimeric antibody; tumor necrosis factor-alpha (TNF-alpha); 3B10; Chinese hamster ovary (CHO) cell;
D O I
10.1016/S0165-2478(98)00097-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A mouse anti-human tumor necrosis factor-alpha (TNF-alpha) monoclonal antibody (MoAb), designated as 3B10, has previously been produced and characterized by our laboratory. We report here the construction and the expression of mouse-human chimeric antibody derived from the MoAb. cDNAs encoding variable regions of heavy and light chains were prepared from 3B10 cells by polymerase chain reaction, and introduced to mammalian expression vectors containing cDNA for human gamma 1 and kappa constant regions, respectively. Cotransfection of the vectors into CHO cells resulted in production of antibody reacting with human TNF-alpha. In SDS-PAGE analysis, the chimeric antibody, c3B10, migrated at 170 kDa under a nonreducing condition, whereas two bands with 58 and 28 kDa appeared following treatment with 2-mercaptoethanol. Both c3B10 and mouse 3B10 neutralized the cytotoxic activity of human TNF-alpha to the same level, indicating that c3B10 holds the binding activity of its original MoAb. These findings suggest that the introduced genes for chimeric heavy and light chains are transcribed and translated to produce the chimeric heavy and light chain peptides, and that the peptides are assembled to form native IgG molecule. The chimeric anti-TNF-alpha antibody described in this study is expected to be less immunogenic and thus more suitable for possible clinical use. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 26 条
[1]   TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION - A COMMON MEDIATOR [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :505-518
[2]   PRODUCTION OF FUNCTIONAL CHIMAERIC MOUSE HUMAN-ANTIBODY [J].
BOULIANNE, GL ;
HOZUMI, N ;
SHULMAN, MJ .
NATURE, 1984, 312 (5995) :643-646
[3]   THE IMMUNOGENICITY OF CHIMERIC ANTIBODIES [J].
BRUGGEMANN, M ;
WINTER, G ;
WALDMANN, H ;
NEUBERGER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2153-2157
[4]   HUMANIZED ANTIBODIES FOR THERAPY [J].
CO, MS ;
QUEEN, C .
NATURE, 1991, 351 (6326) :501-502
[5]   TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES LETHAL ACTIVITY OF KILLED GRAM-NEGATIVE AND GRAM-POSITIVE BACTERIA IN D-GALACTOSAMINE-TREATED MICE [J].
FREUDENBERG, MA ;
GALANOS, C .
INFECTION AND IMMUNITY, 1991, 59 (06) :2110-2115
[6]   A SANDWICH ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HUMAN INTERLEUKIN-5 [J].
FUKUDA, Y ;
HASHINO, J ;
HARUYAMA, M ;
TSURUOKA, N ;
NAKAZATO, H ;
NAKANISHI, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 143 (01) :89-94
[7]   TUMOR NECROSIS FACTORS - GENE STRUCTURE AND BIOLOGICAL-ACTIVITIES [J].
GOEDDEL, DV ;
AGGARWAL, BB ;
GRAY, PW ;
LEUNG, DW ;
NEDWIN, GE ;
PALLADINO, MA ;
PATTON, JS ;
PENNICA, D ;
SHEPARD, HM ;
SUGARMAN, BJ ;
WONG, GHW .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1986, 51 :597-609
[8]  
GRAY GE, 1987, SCIENCE, V237, P1210
[9]  
HIRAI M, 1987, J IMMUNOL METHODS, V96, P57
[10]   TUMOR NECROSIS FACTOR IDENTIFIED IN MULTIPLE-SCLEROSIS BRAIN [J].
HOFMAN, FM ;
HINTON, DR ;
JOHNSON, K ;
MERRILL, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :607-612